Just a couple of days ago, I wrote a column about aducamumab (Aduhelm), a new Alzheimer’s treatment from Biogen. Medicare just announced that they agree with me.
Update: Medicate Is Not Planning To Pay For Expensive New Alzheimer’s Drug
Just a couple of days ago, I wrote a column about aducamumab (Aduhelm), a new Alzheimer’s treatment from Biogen. Medicare just announced that they agree with me.